April 21, 2015RadiologyOpen Access

Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of¹⁸F-FDG Uptake at PET—Association with Treatment Response and Prognosis

View Full Paper

Ask AI

Bookmark

Abstract

Response to erlotinib is associated with reduced heterogeneity at (18)F-FDG PET. Changes in first-order entropy are independently associated with OS and treatment response.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cook et al. (2015) studied this question.

synapsesocial.com/papers/69d8e70b183921ebcaae3f3e https://doi.org/10.1148/radiol.2015141309

View Full Paper

Ask AI

Bookmark

Abstract

Response to erlotinib is associated with reduced heterogeneity at (18)F-FDG PET. Changes in first-order entropy are independently associated with OS and treatment response.

Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of¹⁸F-FDG Uptake at PET—Association with Treatment Response and Prognosis

Abstract

Discussion

Cite This Study

Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of¹⁸F-FDG Uptake at PET—Association with Treatment Response and Prognosis

Abstract

Discussion

Cite This Study

Also Consider

Also Consider